Multivitamins Help Delay Antiretroviral Use Among New HIV Patients, Study Shows

“New research from Africa suggests that basic multivitamin and selenium supplements might greatly lower the risk that untreated people with the AIDS virus will get sicker over a two-year period,” HealthDay News reports (Dotinga, 11/26). “Patients taking a daily combination of vitamins B, C and E along with selenium for two years were able to delay their need for antiretroviral therapies by about half compared with those given a placebo, according to research published in the Journal of the American Medical Association,” Bloomberg writes. “The findings are the first to show that vitamins and selenium can postpone illness in newly diagnosed HIV patients (Ostrow, 11/27). Study author Marianna Baum of Florida International University’s Stempel School of Public Health “didn’t have information about the costs of the supplements, but she said they are low,” HealthDay notes (11/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.